Infants with late breast milk acquisition of HIV‐1 generate interferon‐gamma responses more rapidly than infants with early peripartum acquisition
暂无分享,去创建一个
S. Rowland-Jones | J. Overbaugh | G. John-Stewart | C. Farquhar | B. Lohman-Payne | E. Maleche-Obimbo | B. Richardson | J. Slyker | M. Majiwa | D. Mbori-ngacha | J. A. Slyker
[1] S. Rowland-Jones,et al. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. , 2007, The Journal of clinical investigation.
[2] B. Walker,et al. Human Immunodeficiency Virus-Specific CD8+ T-Cell Activity Is Detectable from Birth in the Majority of In Utero-Infected Infants , 2007, Journal of Virology.
[3] D. Nixon,et al. Strong HIV-1-Specific T Cell Responses in HIV-1-Exposed Uninfected Infants and Neonates Revealed after Regulatory T Cell Removal , 2006, PloS one.
[4] C. Chougnet,et al. Defective antigen-presenting cell function in human neonates. , 2006, Clinical immunology.
[5] W. Fawzi,et al. Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes. , 2006, Virus research.
[6] G. Petitjean,et al. Detection of a large T-cell reservoir able to replicate HIV-1 actively in breast milk , 2006, AIDS.
[7] E. Holmes,et al. Unique Acquisition of Cytotoxic T-Lymphocyte Escape Mutants in Infant Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.
[8] T. Ndung’u,et al. Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. , 2005, The Journal of infectious diseases.
[9] C. Rouzioux,et al. In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy. , 2005, AIDS research and human retroviruses.
[10] S. Rowland-Jones,et al. Longitudinal Assessment of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon Responses during the First Year of Life in HIV-1-Infected Infants , 2005, Journal of Virology.
[11] R. Kaul,et al. Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes , 2004, AIDS.
[12] C. Leclerc,et al. Neonatal adaptive immunity comes of age , 2004, Nature Reviews Immunology.
[13] J. Overbaugh,et al. Predictors of Early Mortality in a Cohort of Human Immunodeficiency Virus Type 1-Infected African Children , 2004, The Pediatric infectious disease journal.
[14] V. Soriano,et al. Care of patients with hepatitis C and HIV co-infection. , 2004, AIDS.
[15] Barbra A. Richardson,et al. Comparison of Human Immunodeficiency Virus Type 1 Viral Loads in Kenyan Women, Men, and Infants during Primary and Early Infection , 2003, Journal of Virology.
[16] R. V. van Lier,et al. Frequencies of Circulating Cytolytic, CD45RA+CD27−, CD8+ T Lymphocytes Depend on Infection with CMV1 , 2003, The Journal of Immunology.
[17] C. Rouzioux,et al. Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children. , 2002, The Journal of infectious diseases.
[18] C. Rousseau,et al. Validation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay with Genital Swabs and Breast Milk Samples , 2002, Journal of Clinical Microbiology.
[19] B. Richardson,et al. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. , 2002, The Journal of infectious diseases.
[20] J. Margolick,et al. Association of Gag-specific T lymphocyte responses during the early phase of human immunodeficiency virus type 1 infection and lower virus load set point. , 2002, The Journal of infectious diseases.
[21] H. Whittle,et al. T cell responses to vaccines in infants: defective IFNγ production after oral polio vaccination , 2002, Clinical and experimental immunology.
[22] R. Koup,et al. Analysis of Total Human Immunodeficiency Virus (HIV)-Specific CD4+ and CD8+ T-Cell Responses: Relationship to Viral Load in Untreated HIV Infection , 2001, Journal of Virology.
[23] R. Schooley,et al. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion. , 2001, The Journal of infectious diseases.
[24] B. Richardson,et al. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial. , 2001, JAMA.
[25] L. Jagodzinski,et al. Evaluation of Performance of the Gen-Probe Human Immunodeficiency Virus Type 1 Viral Load Assay Using Primary Subtype A, C, and D Isolates from Kenya , 2000, Journal of Clinical Microbiology.
[26] J. Overbaugh,et al. Rapid Method for Screening Dried Blood Samples on Filter Paper for Human Immunodeficiency Virus Type 1 DNA , 1999, Journal of Clinical Microbiology.
[27] C. Rouzioux,et al. Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers. , 1998, AIDS research and human retroviruses.
[28] M. Barnardo,et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.
[29] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.